Patents by Inventor Tim N. Ziegenfuss
Tim N. Ziegenfuss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11925645Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: GrantFiled: February 21, 2023Date of Patent: March 12, 2024Assignee: ORTHO-NUTRA, LLCInventors: Hector L. Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Patent number: 11707465Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (Cmax) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.Type: GrantFiled: August 9, 2022Date of Patent: July 25, 2023Assignee: Ortho-Nutra LLCInventors: Hector L. Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Publication number: 20230190757Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: ApplicationFiled: February 21, 2023Publication date: June 22, 2023Applicant: Ortho-Nutra, LLCInventors: Hector L. Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Publication number: 20230147386Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (Cmax) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.Type: ApplicationFiled: August 9, 2022Publication date: May 11, 2023Applicant: Ortho-Nutra, LLCInventors: Hector L. Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Patent number: 11583534Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: GrantFiled: October 30, 2020Date of Patent: February 21, 2023Assignee: Ortho-Nutra, LLCInventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Publication number: 20230025435Abstract: Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Exemplary compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, a metal-containing antioxidant, and optionally an additional ingredient, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions are effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation. More specifically, the contemplated compositions are capable of increasing cellular vitality by inducing expression of OCT4, SOX, and/or KLF4 and/or decreasing biomarkers of cell senescence.Type: ApplicationFiled: January 6, 2021Publication date: January 26, 2023Applicant: JUVN3 Holdings, LLCInventors: Tim N. Ziegenfuss, Matthew Titlow, Hector L. Lopez
-
Patent number: 11426410Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (Cmax) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.Type: GrantFiled: August 26, 2019Date of Patent: August 30, 2022Assignee: Ortho-Nutra, LLCInventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Publication number: 20210137928Abstract: An enhanced caffeinated beverage composition includes a caffeinated drink combined with an effective blend of methylliberine and theacrine providing increased mood, energy, alertness, focus, motivation, and/or decreased fatigue without adversely affecting heart rate or blood pressure.Type: ApplicationFiled: October 30, 2020Publication date: May 13, 2021Applicant: Ortho-Nutra, LLCInventors: Hector L Lopez, Tim N. Ziegenfuss, Matthew Titlow
-
Patent number: 10993978Abstract: Compositions and methods include a synergistically effective combination of glycerol and Phyllanthus emblica extract for increasing muscle volume in response to an exercise stimulus of the corresponding muscle or muscle region.Type: GrantFiled: January 6, 2021Date of Patent: May 4, 2021Assignee: KLZ HOLDINGS, LLCInventors: Tim N. Ziegenfuss, Hector L. Lopez, Bruce W. Kneller
-
Patent number: 10925911Abstract: Compositions and methods include a synergistically effective combination of glycerol and Phyllanthus emblica extract for increasing muscle volume in response to an exercise stimulus of the corresponding muscle or muscle region.Type: GrantFiled: May 6, 2020Date of Patent: February 23, 2021Assignee: KLZ HOLDINGS, LLCInventors: Tim N. Ziegenfuss, Hector L. Lopez, Bruce W. Kneller
-
Publication number: 20200261524Abstract: Compositions and methods include a synergistically effective combination of glycerol and Phyllanthus emblica extract for increasing muscle volume in response to an exercise stimulus of the corresponding muscle or muscle region.Type: ApplicationFiled: May 6, 2020Publication date: August 20, 2020Inventors: Tim N. Ziegenfuss, Hector L. Lopez, Bruce W. Kneller
-
Publication number: 20190374546Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (Cmax) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.Type: ApplicationFiled: August 26, 2019Publication date: December 12, 2019Applicant: Ortho-Nutra, LLCInventors: Hector L. Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Patent number: 10398701Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (Cmax) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.Type: GrantFiled: May 19, 2017Date of Patent: September 3, 2019Assignee: Ortho-Nutra, LLCInventors: Hector L. Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Patent number: 10272091Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue.Type: GrantFiled: November 12, 2014Date of Patent: April 30, 2019Assignee: Ortho-Nutra, LLCInventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Publication number: 20180104248Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue. A synergistic composition comprises co-administration of theacrine and caffeine, wherein the co-administered caffeine reduces theacrine oral clearance (CL/F) and oral volume of distribution (Vd/F). In addition, the co-administered caffeine increases area under the plasma concentration time curve (AUC) of theacrine, and increases theacrine maximum plasma concentration (Cmax) in comparison with the corresponding pharmacokinetic parameters when theacrine is administered alone.Type: ApplicationFiled: May 19, 2017Publication date: April 19, 2018Applicant: Ortho-Nutra, LLCInventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss
-
Publication number: 20150132280Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue.Type: ApplicationFiled: November 12, 2014Publication date: May 14, 2015Applicant: ORTHO-NUTRA, LLCInventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss